ロード中...
First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer
BACKGROUND: Epidermal growth factor receptor (EGFR) mutation positive (M+) non‐small cell lung cancer (NSCLC) is an important subtype of lung cancer comprising 10% to 15% of non‐squamous tumours. This subtype is more common in women than men, is less associated with smoking, but occurs at a younger...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2021
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8092455/ https://ncbi.nlm.nih.gov/pubmed/33734432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010383.pub3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|